These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 33168531)
21. Carcinoid syndrome caused by a serotonin-secreting pituitary tumour. Lynggård LA; Nielsen EH; Laurberg P Eur J Endocrinol; 2014 Feb; 170(2):K5-9. PubMed ID: 24174286 [TBL] [Abstract][Full Text] [Related]
22. Sequential hypoglycemia, hyperglycemia, and the carcinoid syndrome arising from a plurihormonal neuroendocrine neoplasm. Mitzner LD; Nohria A; Chacho M; Inzucchi SE Endocr Pract; 2000; 6(5):370-4. PubMed ID: 11141588 [TBL] [Abstract][Full Text] [Related]
23. [Neuroendocrine tumors of the gastrointestinal tract]. Arnold C Praxis (Bern 1994); 2007 Jan; 96(1-2):19-28. PubMed ID: 17256557 [TBL] [Abstract][Full Text] [Related]
24. Multimodal Treatment of Vasoactive Intestinal Polypeptide-producing Pancreatic Neuroendocrine Tumors with Liver Metastases. Iwasaki M; Tsuchida K; Jinnai H; Komatsubara T; Arisaka T; Tsunemi M; Nakano M; Iijima M; Hiraishi H Intern Med; 2017; 56(5):517-522. PubMed ID: 28250297 [TBL] [Abstract][Full Text] [Related]
25. Carcinoid syndrome, acromegaly, and hypoglycemia due to an insulin-secreting neuroendocrine tumor of the liver. Furrer J; Hättenschwiler A; Komminoth P; Pfammatter T; Wiesli P J Clin Endocrinol Metab; 2001 May; 86(5):2227-30. PubMed ID: 11344231 [TBL] [Abstract][Full Text] [Related]
26. A rare case of ectopic adrenocorticotropic hormone syndrome caused by a metastatic neuroendocrine tumor of the pancreas detected by 68Ga-DOTANOC and 18F-FDG PET/CT. Treglia G; Salomone E; Petrone G; Giaccari A; Rindi G; Rufini V Clin Nucl Med; 2013 Jul; 38(7):e306-8. PubMed ID: 23486330 [TBL] [Abstract][Full Text] [Related]
27. Role of (68)Ga-DOTATOC PET-CT in the diagnosis and staging of pancreatic neuroendocrine tumours. Kumar R; Sharma P; Garg P; Karunanithi S; Naswa N; Sharma R; Thulkar S; Lata S; Malhotra A Eur Radiol; 2011 Nov; 21(11):2408-16. PubMed ID: 21750886 [TBL] [Abstract][Full Text] [Related]
28. Non-islet cell tumour hypoglycaemia in a patient with a well-differentiated gastric neuroendocrine tumour. Versluis J; Valk G; van Rossum H; Tesselaar M BMJ Case Rep; 2019 Sep; 12(9):. PubMed ID: 31527214 [TBL] [Abstract][Full Text] [Related]
29. Principles of diagnosis and management of neuroendocrine tumours. Raphael MJ; Chan DL; Law C; Singh S CMAJ; 2017 Mar; 189(10):E398-E404. PubMed ID: 28385820 [No Abstract] [Full Text] [Related]
30. Hyperinsulinemic hypoglycemia associated with ectopic Cushing's syndrome due to a pancreatic endocrine tumor in a Type 2 diabetes mellitus patient: clinical implications of a rare association. Filippella M; Davì MV; Doveri G; Lillaz E; Ciccarelli A; Massimetti E; Toaiari M; Falconi M; Colao A; Faggiano A J Endocrinol Invest; 2011 Mar; 34(3):175-9. PubMed ID: 20386090 [TBL] [Abstract][Full Text] [Related]
31. Glucagonoma Syndrome: A Rare Paraneoplastic Disorder due to Neuroendocrine Tumor of the Pancreas. Yusuf MA; Mehmood S; Iftikhar J; Saqib M; Siddique MZ; Imtiaz W J Coll Physicians Surg Pak; 2022 Aug; 32(8):S147-S149. PubMed ID: 36210677 [TBL] [Abstract][Full Text] [Related]
32. Ectopic insulinomas in the pelvis secondary to rectum neuroendocrine tumour. Li TN; Liu Z; Zhang Y; Wang F BMJ Case Rep; 2018 Jun; 2018():. PubMed ID: 29960958 [TBL] [Abstract][Full Text] [Related]
35. A case of insulin and ACTH co-secretion by a neuroendocrine tumour. Solomou S; Khan R; Propper D; Berney D; Druce M Endocrinol Diabetes Metab Case Rep; 2014; 2014():130082. PubMed ID: 24683485 [TBL] [Abstract][Full Text] [Related]
36. [Malignant insulinoma]. Tóth M; Szücs N; Jakab Z; Doros A; Nemes Z; Rácz K Orv Hetil; 2011 Mar; 152(10):398-402. PubMed ID: 21354956 [TBL] [Abstract][Full Text] [Related]
37. Simultaneous Glucagon and Vasoactive Intestinal Peptide Producing Pancreatic Neuroendocrine Tumors in a Patient With Multiple Endocrine Neoplasia Type 1: A Case Report and Literature Review. Kim GY; Kim S; Ong RKS; Shawa H Pancreas; 2018 Jan; 47(1):e1-e2. PubMed ID: 29232343 [No Abstract] [Full Text] [Related]
38. Severe hypoglycaemia after long-acting octreotide in a patient with an unrecognized malignant insulinoma. Healy ML; Dawson SJ; Murray RM; Zalcberg J; Jefford M Intern Med J; 2007 Jun; 37(6):406-9. PubMed ID: 17535385 [TBL] [Abstract][Full Text] [Related]
39. CT evaluation of response in advanced gastroenteropancreatic neuroendocrine tumors treated with long-acting-repeatable octreotide: what is the optimal size variation threshold? Luo Y; Chen J; Shen B; Wang M; Cai H; Xu L; Chen L; Chen M; Li ZP; Feng ST Eur Radiol; 2018 Dec; 28(12):5250-5257. PubMed ID: 29876704 [TBL] [Abstract][Full Text] [Related]
40. Reversal of Severe and Refractory Humoral Hypercalcemia With 177Lu-Octreotate Peptide Receptor Radionuclide Therapy for Neuroendocrine Tumor of the Pancreas. Iliuta IA; Beauregard JM; Couture F; Douville P; Mac-Way F Clin Nucl Med; 2015 Sep; 40(9):e448-50. PubMed ID: 26053724 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]